+467.0%
MRNA vs SPXL
+41.9%
+425.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPXL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.4% | +3.0% | +3.8% |
| 7D | -1.1% | -2.5% | +1.4% | +0.6% |
| 30D | +126.1% | -4.2% | +130.3% | +133.4% |
| 3M | +190.0% | +8.1% | +181.9% | +178.1% |
| 6M | +157.2% | +35.6% | +121.6% | +116.2% |
| YTD | +388.2% | +28.8% | +359.4% | +317.9% |
| 1Y | +467.0% | +39.8% | +427.2% | +334.1% |
| All | +467.0% | +41.9% | +425.1% | +334.1% |
Cumulative growth
Daily Returns
Daily percentage return beside SPXL.
Daily Out/Under-Performance
Portfolio return minus SPXL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPXL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPXL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling